COMPANY PROFILE

Ception Therapeutics

Explore full profile

Biopharmaceutical company developing novel products to address areas of unmet medical needs

Malvern, United StatesFounded 2004Biotech & Life Sciences

Valuation $250–500M Last recorded · 2010

Headcount <100 Current team size

Total funding $50–100M Disclosed equity funding

Unlock exact values

About Ception Therapeutics

Ception Therapeutics operates in the biopharmaceutical sector, focusing on the monitoring and analysis of therapeutic effects of various medications. The company serves healthcare providers, researchers, and pharmaceutical companies by providing insights into the efficacy and safety of drugs such as Benazepril, Captopril, Procrit, Aranesp, Xanax, Tramadol, Propecia, and Kamagra. Operating in the global healthcare market, Ception Therapeutics employs a research-driven business model, generating revenue through partnerships, data licensing, and consultancy services. The company leverages its expertise in clinical research to offer high-quality, evidence-based information that aids in the development and optimization of therapeutic treatments. By continuously monitoring and evaluating drug performance, Ception Therapeutics aims to improve patient outcomes and support the advancement of medical science.

MoreLess Source: Dealroom company data

At a glance

Status: Acquired
Founded: 2004
Headquarters: Malvern, United States
Employees: 6
Open positions: None listed
Dealroom signal: 26.0/100
Industry: Health
Sub-industry: Pharmaceutical, BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model: Manufacturing
Client focus: b2c
Links: Website LinkedIn

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

3 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
ACQUISITIONOther financing	Feb 2010	$250M	$250M	Cephalon	—
SERIES COther financing	May 2007	$15M	$59M	New Science Ventures · Aperture Venture Partners · Third Point Ventures · Essex Woodlands Health Ventures	—

Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Ception Therapeutics website traffic

Latest recorded traffic for Ception Therapeutics is 350 monthly website visits, up 150% over the last three months. Ception Therapeutics's team grew 0% over the past year.

Latest monthly visits350 3-month web change+150% 1-year team growth0%

Monthly website visitsApr 2016–Mar 2023

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
OROrchidGenetic testing solutions for personalized health risk assessment and family planning	San Francisco, United States	Operational	65	$17M	$48M
VBVero BiotechAn emerging biotechnology company focused on the design, development, and commercialization of next generation inhaled nitric oxide (NO) delivery systems to address unmet medical needs of patients with cardiopulmonary conditions	Atlanta, United States	Operational
COCorticaCortica is a provider of advanced neurological therapies for children with autism and other developmental differences	San Diego, United States	Operational
GAGalenicumProduction and distribution of pharmaceutical goods in various formats	Esplugues de Llobregat, Spain	Operational
NANanoTheaNanoThea \| Radiopharmaceuticals	Warsaw, Poland	Operational
CPCOMPASS PathwaysPsilocybin-based therapies for treatment-resistant mental health conditions	London, United Kingdom	Operational
ADAdvicenneDevelops and markets pediatric drugs for the treatment of neurological diseases of the central nervous system and nephrological disorders	Paris, France	Operational
SESEPARATIVECreates eco-friendly, purification and analysis solutions for molecule separation in the pharmaceutical and chemical industries	Saint-Fons, France	Closed